HS
ASMB icon

HighVista Strategies’s Assembly Biosciences ASMB Stock Holding History

HighVista Strategies’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
73,405
-1,330
-2% -$36.2K 0.46% 59
2026
Q1 		$2.07M Buy
+74,735
New +$2.13M 0.57% 56
2021
Q1 		– Sell
-1,239
Closed -$90K – 128
2020
Q4 		$90K Sell
1,239
-985
-44% -$116K 0.06% 96
2020
Q3 		$439K Buy
+2,224
New +$560K 0.32% 62

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HighVista Strategies's ASMB Position: Q2 2026 in Review

HighVista Strategies reduced its Assembly Biosciences (ASMB) stake by 1.8% in Q2 2026, selling an estimated $36.2K and leaving 73,405 shares worth $2.02M. The position accounts for 0.46% of the portfolio, ranked #59.

HighVista Strategies first reported a position in ASMB in Q3 2020 and has held it in 4 quarters since. The position peaked at $2.07M in Q1 2026. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • HighVista Strategies held 73,405 shares of Assembly Biosciences worth $2.02M as of Q2 2026.
  • HighVista Strategies sold 1,330 Assembly Biosciences shares in Q2 2026, an estimated $36.2K.
  • Assembly Biosciences made up 0.46% of HighVista Strategies's portfolio in Q2 2026, its #59 holding.
  • HighVista Strategies first reported a position in Assembly Biosciences in Q3 2020 and has held it in 4 quarters since.
  • HighVista Strategies's Assembly Biosciences position peaked at $2.07M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.